News & Events
Dr. Della Valle’s Study wins the Carl L. Nelson, M.D. Physician in Training Award
The Program Committee of the Mid-America Orthopaedic Association has selected one of Dr. Della Valle’s recent studies as the winner of the Carl L. Nelson, M.D. Physician in Training Award.
Dr. Della Valle will be speaking about the study at the Mid-America Orthopaedic Association Annual Meeting on April 15 in Bonita Springs, Florida.
Click here to read an abstract of the study »
Read more at Becker’s Orthopedic Review »
Dr. Della Valle’s Presentation chosen for inclusion in the Best of AAOS
One of Dr. Della Valle’s recent presentations, entitled “Hypoalbuminemia Predicts Joint Infection, Pneumonia, and Readmission After Total Joint Arthroplasty”, has been chosen by the American Academy of Orthopaedic Surgeons (AAOS) for inclusion in their Best of AAOS presentation. The Best of AAOS presentation will take place Friday, March 4, at the AAOS Annual Meeting in Orlando, FL.
Dr. Della Valle appointed Chief of the Division of Adult Reconstructive Service at Rush University Medical Center
Dr. Della Valle has been appointed Chief of the Division of Adult Reconstructive Service at Rush University Medical Center.
Click here to read a Becker’s Orthopedic Review article about the appointment »
Click here to learn more about orthopedic surgery at Rush University Medical Center »
Dr. Della Valle recipient of The Mark Coventry, MD Award
Dr. Della Valle has been selected as the recipient of The Mark Coventry, MD Award for his paper titled, “Oral Antibiotics Reduce Reinfection Following 2-Stage Exchange: A Multi-Center, Randomized Controlled Trial.”.
He will present the paper at The Knee Society/AAHKS Specialty Day program (AAOS 2016 Annual Meeting) on Saturday, March 5, 2016, in, Orlando, FL.
Dual Mobility Implants for an Unstable Total Hip Arthroplasty
In the abstract from his presentation at International Congress for Join Reconstruction’s Pan Pacific Orthoapedic Congress, Dr. Della Valle shares data showing that dual mobility implants are better than constrained liners for patients who present with dislocation after a total hip arthroplasty.
Dr. Della Valle elected to 3rd Vice President of AAHKS
Dr. Della Valle has been elected to 3rd Vice President of American Association of Hip & Knee Surgeons (AAHKS).
Established in 1991, the mission of the AAHKS is to advance hip and knee patient care through education and advocacy.
Dr. Della Valle heads to Japan to give lectures
Dr. Della Valle had the honor of being invited to Kamakura, Japan by Professor Kazuo Hirakawa of the Shonan Kamakura Joint Reconstruction Center to speak at their 3rd annual meeting. While in Japan from October 7th through the 12th, Dr. Della Valle is sharing with his hosts recent research work completed at Rush on the diagnosis and treatment of periprosthetic joint infection, exposures for revision total hip arthroplasty and the management of corrosions reactions in total hip arthroplasty.
Dr. Della Valle’s study wins The James A. Rand Young Investigator’s Award
A recent study that Dr. Della Valle co-authored has won The James A. Rand Young Investigator’s Award. The study is entitled “A Randomized Controlled Trial Of Oral And IV Tranexamic Acid: The Same Efficacy At Lower Cost?”. The award will be presented on November 7th at the annual AAHKS meeting in Dallas, TX.
About the award
The American Association of Hip and Knee Surgeons (AAHKS) established the Young Investigator’s Award in honor of James A. Rand, MD, founding member and past president of AAHKS. The purpose of the Award is to recognize a young investigator who demonstrates clinical excellence in knee-related research.
To be eligible, the young researcher must be the principal investigator of the research submitted, and less than five years in active practice from the date of application.
The most outstanding paper that embodies Dr. Rand’s commitment to the highest standards of orthopaedic knowledge will be selected for presentation at the Annual Meeting.
About the study
Blood loss is a concern after hip and knee arthroplasty. Tranexamic acid, is a medication that is used commonly to reduce blood loss and the risk of transfusion after surgery. Tranexamic acid is usually given intravenously at the time of surgery.
In this study, we compared the use of an oral formulation of tranexamic acid to the IV form. The oral form is much less expensive and we found in this study that the oral form was just as effective. This study could lead to substantial cost savings for our health care system, in the range of $50 million dollars per year given that nearly 1,000,000 hip and knee replacements are performed in the United States every year.
Click here to learn more about the award »
Click here to read the study’s abstract »
Dr. Della Valle Featured in Elmhurst Suburban Life
Dr. Della Valle is featured in a recent article in the Elmhurst Suburban Life newspaper. Entitled, “Elmhurst teen to share her story of overcoming adversity at Arthritis Foundation gala”, the article describes the experience of a thirteen year-old girl who received hip replacement surgery from Dr. Della Valle.
Dr. Della Valle recommends three recent journal articles
Dr. Della Valle recommends the following journal articles that have recently been published:
A new study shows hyaluronic acid knee injections no better than placebo – Click here for abstract.
Study suggests super morbidly obese patients have very high risk of complications after knee replacement – Click here for anstract.
Web information on direct anterior hip replacement may not in many cases be accurate – Click here for abstract.
